Rivaroxaban and other non-vitamin K antagonist oral anticoagulants in the emergency treatment of thromboembolism

International Journal of Emergency Medicine

Eric Wiel³  Kurt Huber¹  Nicolas Danchin⁴  Patrick Goldstein³  Ismaïl Elalamy² 

[1] 3rd Department of Internal Medicine, Cardiology and Emergency Medicine, Wilhelminenspital, Vienna, Austria3rd Department of Internal Medicine, Cardiology and Emergency Medicine, Wilhelminenspital, Vienna, Austria3rd Department of Internal Medicine, Cardiology and Emergency Medicine, Wilhelminenspital, Vienna, Austria;Department of Haematology, Hôpital Tenon, Paris, FranceDepartment of Haematology, Hôpital Tenon, Paris, FranceDepartment of Haematology, Hôpital Tenon, Paris, France;Department of Emergency Medicine, CHRU de Lille, Lille, FranceDepartment of Emergency Medicine, CHRU de Lille, Lille, FranceDepartment of Emergency Medicine, CHRU de Lille, Lille, France;Hôpital Européen Georges-Pompidou, Paris, FranceHôpital Européen Georges-Pompidou, Paris, FranceHôpital Européen Georges-Pompidou, Paris, France

关键词: Acute thrombosis;    Emergency setting;    Oral anticoagulant;    Pulmonary embolism;   

DOI  :  10.1186/1865-1380-6-25

学科分类：农业科学（综合）

来源: Springer

【 授权许可】

Unknown